| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/18/2007 | WO2007006573A2 Variant iaspp polypeptide and screening assay |
| 01/18/2007 | WO2007006101A1 Surface proteins of pasteurella multocida |
| 01/18/2007 | WO2006125914A3 Use of h11 protein in in vitro diagnosis of streptococcus pyogenes infections |
| 01/18/2007 | WO2006117240A3 Novel method for preventing or treating m tuberculosis infection |
| 01/18/2007 | WO2006107183A8 Mussel bioadhesive |
| 01/18/2007 | WO2006083514A3 Transgenic production of spider silk |
| 01/18/2007 | WO2006079565A3 Leishmania antigens suitable for a diagnostic kit of leishmania |
| 01/18/2007 | WO2006069610A3 Process for the production of fine chemicals |
| 01/18/2007 | WO2006066003A3 Methods and compositions for induction or promotion of immune tolerance |
| 01/18/2007 | WO2006063182A3 Orthopic reconstituted human breast tumor model in mouse |
| 01/18/2007 | WO2006060699A3 Methods of increasing seed yield |
| 01/18/2007 | WO2006056464A3 Compound with affinity for the cytotoxic t lymphocyte-associated antigen (ctla-4) |
| 01/18/2007 | WO2006048234A3 Diagnosis and therapy of autophagy-associated diseases |
| 01/18/2007 | WO2006031378A3 Progesterone receptor structure |
| 01/18/2007 | WO2006028595A3 Muteins of fibroblast growth factor 21 |
| 01/18/2007 | WO2006026002A3 T cell receptors with enhanced sensitivity recognition of antigen |
| 01/18/2007 | WO2005124341A8 Stable isotope labeled polypeptide standards for protein quantitation |
| 01/18/2007 | WO2005116189A3 Compositions and use of inflammation-20 (inf-20) gene |
| 01/18/2007 | WO2005113017A3 Gfap-based gene therapy for treatment of retinal diseases |
| 01/18/2007 | WO2005111058A9 Intracellular delivery of osteoinductive proteins and peptides |
| 01/18/2007 | WO2005098043A3 Ligand-dependent protein splicing |
| 01/18/2007 | WO2005069726A3 Hybrid and chimeric polypeptides that regulate activation of complement |
| 01/18/2007 | WO2005042695A3 Lipoparticles comprising proteins, methods of making, and using the same |
| 01/18/2007 | WO2004061122A3 Cell proliferation-related polypeptides and uses therefor |
| 01/18/2007 | WO2004054510A3 Method for identifying modulators of human orexin-2 receptor |
| 01/18/2007 | WO2004016762A3 Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer |
| 01/18/2007 | WO2003089582A3 Multimeric ligands with enhanced stability |
| 01/18/2007 | US20070016979 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots |
| 01/18/2007 | US20070016977 Gene resistant to aphis gossypii |
| 01/18/2007 | US20070016971 Constitutive promoter from the Taro bacilliform virus (TaBV) for expression of foreign or endogenous coding sequences in plants; transcript capable of modulating expression of a target gene; Alomae disease of taro (Colocasia esculenta), badnavirus |
| 01/18/2007 | US20070016969 Expression vector for hirudin and transformed cells and transgenic animals containing said vector |
| 01/18/2007 | US20070016968 Treatment of pain through expression of opioid receptors |
| 01/18/2007 | US20070016967 Novel IFNgamma-like polypeptides |
| 01/18/2007 | US20070016380 Protein engineering |
| 01/18/2007 | US20070015913 Mrp3 genes and uses thereof |
| 01/18/2007 | US20070015910 Continuous process for production of oil seed protein isolate |
| 01/18/2007 | US20070015909 Adiponectin variants |
| 01/18/2007 | US20070015908 123 human secreted proteins |
| 01/18/2007 | US20070015907 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 01/18/2007 | US20070015906 Novel essential fungal polynucleotides, polypeptides, and methods of use |
| 01/18/2007 | US20070015737 Compounds for inhibiting diseases and preparing cells for transplantation |
| 01/18/2007 | US20070015721 Hiv-gag codon-optimised dna vaccines |
| 01/18/2007 | US20070015712 Reducing or inhibiting growth or survival of bacteria, viruses and fungi in foods, contact lens and eye wash solutions, and surfaces; oral or injection administration to mammals |
| 01/18/2007 | US20070015708 Methods and compositions for inhibiting tumor growth and angiogenesis |
| 01/18/2007 | US20070015706 Variant comprises a deactivated plasminogen activator inhibitor (PAI) binding site and a platelet integrin binding site within the tPA serine protease domain; anticoagulants; polynucleotides, vectors, and host cells; acute myocardial infarction, cardiovascular disorders; pharmacokinetics |
| 01/18/2007 | US20070015704 Cancer drug target; useful in diagnostic, prophylactic, prognostic, of certain cancers |
| 01/18/2007 | US20070015700 Mammalian genes modulated during fasting and feeding |
| 01/18/2007 | US20070015699 provide for inhibition of tumor necrosis factor -TNF alpha signal transduction and the associated immune inflammatory responses; used in treatment of Crohn's disease, psoriasis, rheumatoid arthritis, graft versus host disease etc; vector; isolated cell |
| 01/18/2007 | US20070015696 621 human secreted proteins |
| 01/18/2007 | US20070015695 Three-dimensional structures of TALL-1 and its cognate receptors and modified proteins and methods related thereto |
| 01/18/2007 | US20070015282 Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 01/18/2007 | US20070015269 Crystals of DPP-IV |
| 01/18/2007 | US20070015258 Alpha-beta C4BP -type recombinant heteromultimeric proteins |
| 01/18/2007 | US20070015257 Alpha-MSH related compounds and methods of use |
| 01/18/2007 | US20070015256 molecular targets for diagnostics, prophylaxis and treatment of bacterial infection; cell comprising the recombinant expression vector |
| 01/18/2007 | US20070015255 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 01/18/2007 | US20070015253 Heterologous; biologically active protein fused via a proteolytic cleavage site to a latency associated peptide which having a precursor domain of transforming growth factor beta; overcomes the toxic effect of systemic administration of potent biological agents |
| 01/18/2007 | US20070015252 Corynebacterium glutamicum genes encoding regulatory proteins |
| 01/18/2007 | US20070015248 Expression vector and use thereof |
| 01/18/2007 | US20070015247 Apolipoprotein receptor specific monoclonal antibody for use in the prevention and treatment of cell proliferative disorders |
| 01/18/2007 | US20070015246 STAMP2 nucleic acid molecules; urogenital system for detection, prevention and treatment of cancer |
| 01/18/2007 | US20070015242 Expression vector comprising nucleotide sequences coding C-terminal 28kDa endostatin-spanning proteolytic fragment for use in prevention and treatment of vision defcets associated with cell proliferative disorders |
| 01/18/2007 | US20070015220 Novel guanosine triphosphate (GTP) binding protein-coupled receptor proteins |
| 01/18/2007 | US20070015219 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 01/18/2007 | US20070015215 Modified phycobilisomes and uses therefor |
| 01/18/2007 | US20070015206 Method for detecting and/or removing protien comprising a cross-beta structure from a pharmaceutical composition |
| 01/18/2007 | US20070015204 Methods for treating viral infection using il-28 and il-29 |
| 01/18/2007 | US20070015202 Atlastin |
| 01/18/2007 | US20070015201 Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor |
| 01/18/2007 | US20070015199 Stabilized immunogenic HBc chimer particles |
| 01/18/2007 | US20070015196 Growth factor with acts through Erb B-4 RTK |
| 01/18/2007 | US20070015173 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 01/18/2007 | US20070015164 Dairy cattle breeding for improved milk production traits in cattle |
| 01/18/2007 | US20070015163 Novel full-length cDNA |
| 01/18/2007 | US20070015161 Drug screening for mitotic inhibitor drugs; cancer |
| 01/18/2007 | US20070015155 Novel protein usable in screening drug improving type 2 diabetes |
| 01/18/2007 | US20070015154 Differentially expressed nucleic acids that correlate with ksp expression |
| 01/18/2007 | US20070015150 Novel nucleic acid sequences and proteins of tumors and neoplasias of the thyroid gland |
| 01/18/2007 | US20070015149 Prlz regulatory elements in the treatment of disease and the discovery of therapeutics |
| 01/18/2007 | US20070015144 Human cDNAs and proteins and uses thereof |
| 01/18/2007 | US20070015133 Method for detecting and/or removing protein and/or peptide comprising a cross-beta structure from an aqueous solution comprising a protein |
| 01/18/2007 | US20070014890 Genetically-modified yeasts which can float in a liquid medium, production method thereof and use of same |
| 01/18/2007 | US20070014814 Webbed HIV envelope immunogens, methods for production and use of same |
| 01/18/2007 | US20070014813 Immunogenic polypeptide comprising adjuvant (alum); coupled to diphtheria toxoid; diagnosis and treatment |
| 01/18/2007 | US20070014812 Carrier proteins for vaccines |
| 01/18/2007 | US20070014810 Epitope based vaccines directed towards HPV; side effect reduction; vaccination |
| 01/18/2007 | US20070014809 B Cell Activation and Polypeptides Having CD14 Activity |
| 01/18/2007 | US20070014808 Vaccine composition comprising non-human, mammalian 5T4 antigen for prevention of cell proliferative disorders |
| 01/18/2007 | US20070014807 Multiplex vaccine |
| 01/18/2007 | US20070014804 Peptidic nanoparticles as drug delivery and antigen display systems |
| 01/18/2007 | US20070014800 Cytokine zalpha11 ligand antibodies |
| 01/18/2007 | US20070014798 Antibodies to dendritc cells and human dendritic cell populations and uses thereof |
| 01/18/2007 | US20070014796 Method for the production of non-immunogenic proteins |
| 01/18/2007 | US20070014794 preparing heteromultimeric polypeptides such as bispecific antibodies, bispecific immunoadhesins and antibody-immunoadhesin chimeras; yields of the heteromultimer over other unwanted end-products such as homomultimers |
| 01/18/2007 | US20070014793 Antibodies which activate an erythropoietin receptor |
| 01/18/2007 | US20070014790 Transcription control factor zhx3 |
| 01/18/2007 | US20070014787 71 human secreted proteins |
| 01/18/2007 | US20070014768 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 01/18/2007 | US20070014767 TGFbeta1-inhibitor peptides |
| 01/18/2007 | US20070014766 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |